Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease.
Rebecca Hill,Sanne Kuijper,Janet Lindsey,Ed Schwalbe,Karen Barker,Jessica Boult,Daniel Williamson,Zai Ahmad,Albert Hallsworth,Sarra Ryan,Evon Poon,Simon Robinson,Ruth Ruddle,Florence Raynaud,Louise Howell,Colin Kwok,Abhijit Joshi,Sarah Leigh Nicholson,Stephen Crosier,Stephen Wharton,Keith Robson,Antony Michalski,Darren Hargrave,Thomas Jacques,Barry Pizer,Simon Bailey,Fredrik Swartling,Kevin Petrie,William Weiss,Louis Chesler,Steven Clifford Cancer Cell(2015)
Key words
Medulloblastoma,p53
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper